Citation:Park S, Holmes-Tisch AJ, Cho EY, Shim YM, Kim J, Kim HS, et al 2009

From Cancer Guidelines Wiki

Citation


Park S, Holmes-Tisch AJ, Cho EY, Shim YM, Kim J, Kim HS, et al. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J Thorac Oncol 2009 Jul;4(7):809-15 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19487967.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Park S, Holmes-Tisch AJ, Cho EY, Shim YM, Kim J, Kim HS, et al 2009What specimen types are suitable for mutation testing in NSCLC patients?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What specimen types are suitable for mutation testing in NSCLC patients?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What specimen types are suitable for mutation testing in NSCLC patients?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What specimen types are suitable for mutation testing in NSCLC patients?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Park_S,_Holmes-Tisch_AJ,_Cho_EY,_Shim_YM,_Kim_J,_Kim_HS,_et_al_2009&oldid=112726"